Kadcef Tablet DT is a combination pharmaceutical formulation containing Cefixime 200 mg and Lactobacillus 60 million spores, designed for the treatment of bacterial infections while supporting gastrointestinal health. Cefixime, a third-generation cephalosporin antibiotic, exhibits broad-spectrum activity against a variety of Gram-positive and Gram-negative bacteria by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. It is commonly indicated for infections such as urinary tract infections, respiratory tract infections, otitis media, and uncomplicated gonorrhea. The inclusion of Lactobacillus, a probiotic strain, helps restore and maintain the natural balance of intestinal flora, which can be disrupted during antibiotic therapy, thereby reducing the risk of antibiotic-associated diarrhea and promoting gut health. Kadcef Tablet DT is formulated as a dispersible tablet for ease of administration, especially in patients with swallowing difficulties. The combination therapy aims to provide effective antimicrobial action while minimizing gastrointestinal side effects commonly associated with antibiotic use. It should be used under medical supervision, with dosage and duration tailored according to the severity and type of infection. Caution is advised in patients with known hypersensitivity to cephalosporins or probiotics.